Cargando…

Urgency and necessity of Epstein-Barr virus prophylactic vaccines

Epstein-Barr virus (EBV), a γ-herpesvirus, is the first identified oncogenic virus, which establishes permanent infection in humans. EBV causes infectious mononucleosis and is also tightly linked to many malignant diseases. Various vaccine formulations underwent testing in different animals or in hu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Ling, Krummenacher, Claude, Zhang, Wanlin, Hong, Junping, Feng, Qisheng, Chen, Yixin, Zhao, Qinjian, Zeng, Mu-Sheng, Zeng, Yi-Xin, Xu, Miao, Zhang, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734748/ https://www.ncbi.nlm.nih.gov/pubmed/36494369 http://dx.doi.org/10.1038/s41541-022-00587-6

Ejemplares similares

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
por: Zhong, Ling, et al.
Publicado: (2022)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
por: Zhao, Bingchun, et al.
Publicado: (2018)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
por: Wu, Qian, et al.
Publicado: (2023)

Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses
por: Chen, Haiwen, et al.
Publicado: (2021)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
por: Zhang, Xiao, et al.
Publicado: (2020)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
por: Gu, Ai-Di, et al.
Publicado: (2012)

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
por: Jean-Pierre, Vincent, et al.
Publicado: (2021)

Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses
por: Kong, Xiang-Wei, et al.
Publicado: (2022)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
por: Balfour, Henry H., et al.
Publicado: (2022)

Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein–Barr virus infection
por: Dai, Dan-Ling, et al.
Publicado: (2021)

Induction of chemokine (C‐C motif) ligand 5 by Epstein–Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma
por: Ma, Wenlong, et al.
Publicado: (2018)

Correction: Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein–Barr virus infection
por: Dai, Dan-Ling, et al.
Publicado: (2021)

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
por: Brooks, Jill M., et al.
Publicado: (2016)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Quantification of Epstein-Barr Virus DNA in Patients with Idiopathic Orbital Inflammatory Pseudotumor
por: Jin, Rui, et al.
Publicado: (2013)

Correlation of nasopharyngeal carcinoma with rare earth elements and the Epstein-Barr virus
por: Zhang, Xiangmin, et al.
Publicado: (2018)

Epstein-Barr Virus (EBV) Infection in Chinese Children: A Retrospective Study of Age-Specific Prevalence
por: Xiong, Geng, et al.
Publicado: (2014)

Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma
por: Li, Rui-Chen, et al.
Publicado: (2016)

Structure of Epstein-Barr virus tegument protein complex BBRF2-BSRF1 reveals its potential role in viral envelopment
por: He, Hui-Ping, et al.
Publicado: (2020)

Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Zhu, Qian-Ying, et al.
Publicado: (2020)

Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation
por: Zhang, Hao-Jiong, et al.
Publicado: (2018)

Emergency mental health legislation in response to the Covid-19 (Coronavirus) pandemic in Ireland: Urgency, necessity and proportionality
por: Kelly, Brendan D.
Publicado: (2020)

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
por: Peng, Rou-Jun, et al.
Publicado: (2018)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Characterization of the Prognostic Values of CXCL Family in Epstein–Barr Virus Associated Gastric Cancer
por: Mu, Li, et al.
Publicado: (2022)

Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
por: Xu, Miao, et al.
Publicado: (2019)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
por: Zhu, Qian-Ying, et al.
Publicado: (2021)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d12jk7os2t9m8nehps912v8mfb